United States starts testing first Coronavirus vaccines against covid-19 on human


The first Coronavirus vaccine trials against the new COVID-19 coronavirus commenced in the United States on Monday on human volunteers. The vaccine will be tested on a group of 45 healthy volunteers at the Kaiser Permanente research center in the city of Seattle. According to a press release from that institution, the first four volunteers already received this Monday the corresponding dose of this clinical trial backed by the Donald Trump government.
United States starts testing first Coronavirus vaccines against covid-19 on human

The first Coronavirus vaccine trials against the new COVID-19 coronavirus commenced in the United States on Monday on human volunteers.

The vaccine will be tested on a group of 45 healthy volunteers at the Kaiser Permanente research center in the city of Seattle.
According to a press release from that institution, the first four volunteers already received this Monday the corresponding dose of this clinical trial backed by the Donald Trump government.

The vaccine cannot cause covid-19 but it contains a harmless genetic code copied from the virus that causes the disease.
According to experts, it will take several months to know if this vaccine works or others that are in development.

Research at a forced pace

Scientists around the world are trying to speed up the pace of research.
In the case of these first human trials, funded by the National Institutes of Health (NIH), they are skipping a previous step that is normally used in this type of study: first making sure that the vaccine is capable of eliciting an immune response in animals.
But the biotech company behind this research, Moderna Therapeutics, claims that the vaccine was created using a process of proven reliability.

This coronavirus vaccine uses pre-existing technology. 

It was created to a very high standard, employing things that we know are safe for people, and those who participate in the trial will be subjected to very rigorous monitoring, says Dr. John Tregoning, an expert in infectious diseases from Imperial College London.
Yes, this is very fast, but this is a race against the coronavirus, not against other scientists, and it is being done for the good of humanity, he adds.
Vaccines against viruses - such as measles - are usually made with weak or dead samples of the virus.
But the mRNA-1273 vaccine was not created with the virus that causes covid-19.
Instead, it includes a small segment of a genetic code copied from the virus that scientists have been able to create in a laboratory.

Hopefully this will prepare the body's own immune system to fight the actual infection.

Volunteers will receive different doses of the experimental vaccine. Each of them will be punctured in the arm twice, 28 days apart between doses.
But even if these initial tests go well, it could still take up to 18 months for a potential vaccine to be available to the general public.

Share:

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

ad

Popular News

Recent Posts